Your browser doesn't support javascript.
loading
Selective Serotonin Reuptake Inhibitor (SSRI) Bleeding Risk: Considerations for the Consult-Liaison Psychiatrist.
McFarland, Daniel; Merchant, Dale; Khandai, Abhisek; Mojtahedzadeh, Mona; Ghosn, Omar; Hirst, Jeremy; Amonoo, Hermioni; Chopra, Depti; Niazi, Shehzad; Brandstetter, Jennifer; Gleason, Andrew; Key, Garrett; di Ciccone, Barbara Lubrano.
Afiliación
  • McFarland D; Department of Psychiatry, University of Rochester Medical Center, Rochester, NY, USA. danielcurtismcfarland@gmail.com.
  • Merchant D; Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA. danielcurtismcfarland@gmail.com.
  • Khandai A; Department of Psychiatry, Westmead Hospital, Westmead, NSW, Australia.
  • Mojtahedzadeh M; Department of Consultation-Liaison Psychiatry, Concord Repatriation General Hospital, Sydney, NSW, Australia.
  • Ghosn O; Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Hirst J; Department of Psychiatry, University of California Los Angeles, Los Angeles, CA, USA.
  • Amonoo H; Simms-Mann Center for Integrative Oncology, University of California Los Angeles, Los Angeles, CA, USA.
  • Chopra D; Department of Psychiatry, University of California San Diego, La Jolla, San Diego, CA, USA.
  • Niazi S; Department of Psychiatry, University of California San Diego, La Jolla, San Diego, CA, USA.
  • Brandstetter J; Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, USA.
  • Gleason A; Department of Psychosocial Oncology, Dana-Farber Cancer Center, Boston, MA, USA.
  • Key G; Department of Psychiatry, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA.
  • di Ciccone BL; Department of Psychiatry, Mayo Clinic, Jacksonville, FL, USA.
Curr Psychiatry Rep ; 25(3): 113-124, 2023 03.
Article en En | MEDLINE | ID: mdl-36708455
PURPOSE OF REVIEW: To present a clinically oriented review of selective serotonin reuptake inhibitor (SSRI)-related bleeding issues commonly addressed by consult-liaison psychiatrists. RECENT FINDINGS: Concomitant medical, surgical, or hospital-based conditions exacerbate the risk of SSRI-related bleeding even though a review of the literature suggests it is only marginally elevated. Psychiatrists and other clinicians need to consider these conditions along with antidepressant benefits when answering the question: to start, hold, continue, or change the antidepressant? Where an evidence base is limited, mechanistic understanding may help consult-liaison psychiatrists navigate this terrain and collaborate with other medical specialties on responsible antidepressant management. Most often, the risk is cumulative; data are not directly applicable to complex clinical situations. This review incorporates a hematologic perspective and approach to bleeding risk assessment along with extant data on SSRI-induced bleeding risk ad specific medical conditions.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psiquiatría / Inhibidores Selectivos de la Recaptación de Serotonina Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Curr Psychiatry Rep Asunto de la revista: PSIQUIATRIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Psiquiatría / Inhibidores Selectivos de la Recaptación de Serotonina Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Curr Psychiatry Rep Asunto de la revista: PSIQUIATRIA Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos